Topo
O site do Hospital Beatriz Ângelo usa cookies para assegurar uma experiência de utilização adequada e para conhecer o fluxo de visitas e suas características.
Ao navegar neste site está a consentir a utilização de cookies. Para mais informações consulte a Política de Cookies.
Serviço Nacional de Saúde
República Portuguesa

Hospital Beatriz Ângelo

Navegação Principal do site

Ensaios clínicos em recrutamento



Ensaios clínicos na área do carcinoma mama:
  • OLYMPIA: A randomised, double-blind, parallel group, placebo-controlled multi-centre Phase III study to assess the efficacy and safety of olaparib versus placebo as adjuvant treatment in patients with germline BRCA1/2 mutations and high risk HER2 negative primary breast cancer who have completed definitive local treatment and neoadjuvant or adjuvant chemotherapy. 
Mais informações em: 
https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-003839-30/PT


Ensaios clínicos na área da colite ulcerosa:
  • GARDENIA: Phase III, Randomized, Multicenter Double Blind, Double Dummy Study to evaluate the efficacy and safety of Etrolizumab compared with infliximab in patients with moderate to severe active ulcerative colitis who are naive to TNF inhibitors. 
Mais informações em: 
https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-004282-14/PT

 
Ensaios clínicos na área da diabetes:

    • FIDELIO: A randomized, double-blind, placebo-controlled, parallel-group, multicenter, event-driven Phase III study to investigate the efficacy and safety of finerenone, in addition to standard of care, on the progression of kidney disease in subjects with type 2 diabetes mellitus and the clinical diagnosis of diabetic kidney disease.

    • FIGARO: A randomized, double-blind, placebo-controlled, parallel-group, multicenter, event-driven Phase III study to investigate the efficacy and safety of finerenone on the reduction of cardiovascular morbidity and mortality in subjects with type 2 diabetes mellitus and the clinical diagnosis of diabetic kidney disease in addition to standard of care. 


    Ensaios clínicos na área da doença de Alzheimer:
    • 221AD301: A Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Aducanumab (BIIB037) in Subjects with Early Alzheimer's Disease
         Mais informações em: 


    Ensaios clínicos na área da esclerose múltipla:
    • COMB157G2302: A randomized, double-blind, double-dummy, parallel-group study comparing the efficacy and safety of ofatumumab versus teriflunomide in patients with relapsing multiple sclerosis.

    Mais informações em: 

    Ensaios clínicos na área das infeções respiratórias:
    Ensaios clínicos na área do AVC:
    • RESPECT ESUS: Randomized, double-blind, Evaluation in secondary Stroke Prevention comparing the Efficacy and safety of the oral Thrombin inhibitor dabigatran etexilate (110 mg or 150 mg, oral b.i.d.) versus acetylsalicylic acid (100 mg oral q.d.) in patients with Embolic Stroke of Undetermined Source
    Mais informações em: 
    https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-003444-24/PT

    Ensaios clínicos na área do HIV-2
    • DTG-01-01: A Phase II, Multicenter, Single-Arm, Open-Label Clinical Trial to Evaluate the Safety and Efficacy of Triple Therapy with Dolutegravir plus 2 NRTIs, in Treatment-Naïve HIV-2 Infected Subjects


    voltar
     
     
    Luz Saúde, S.A., Sociedade Aberta © 2017